Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 218,700 | 141,800 | 182,800 | 178,600 | 48,900 |
| Marketable Securities | 8,100 | 49,400 | N/A | N/A | N/A |
| Receivables | 204,700 | 145,300 | 127,100 | 118,500 | 119,400 |
| Inventories | 151,800 | 152,600 | 142,100 | 131,500 | 127,700 |
| Income taxes - deferred | 42,400 | 30,200 | 21,800 | 27,600 | 21,100 |
| Other current assets | 35,500 | 41,700 | 32,100 | 0 | 8,200 |
| TOTAL | $691,900 | $586,400 | $531,600 | $514,200 | $367,500 |
| Non-Current Assets | |||||
| PPE Net | 230,100 | 228,200 | 213,000 | 201,900 | 201,700 |
| Investments And Advances | 14,700 | 34,300 | 20,200 | 10,700 | 20,600 |
| Intangibles | 412,600 | 472,800 | 453,800 | 475,400 | 490,300 |
| Other Non-Current Assets | 50,900 | 28,100 | 28,200 | 26,900 | 32,600 |
| TOTAL | $708,300 | $763,400 | $715,200 | $714,900 | $745,200 |
| Total Assets | $1,400,200 | $1,349,800 | $1,246,800 | $1,229,100 | $1,112,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 150,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 65,600 | 63,900 | 48,900 | 60,700 | 195,400 |
| Accrued Expenses | 186,700 | 161,500 | 140,300 | 108,300 | N/A |
| TOTAL | $258,500 | $380,100 | $226,200 | $194,200 | $195,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 175,500 | 61,700 | 235,900 | 316,100 | 267,100 |
| Other Non-Current Liabilities | 87,400 | 73,000 | 35,300 | 28,800 | 22,100 |
| TOTAL | $262,900 | $134,700 | $271,200 | $344,900 | $289,200 |
| Total Liabilities | $521,400 | $514,800 | $497,400 | $539,100 | $484,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 670,503 | 680,279 | 694,591 | 710,879 | 714,998 |
| Common Shares | 73,700 | 68,600 | 67,000 | 65,600 | 64,200 |
| Retained earnings | 676,900 | 548,600 | 433,900 | 303,400 | 224,100 |
| Other shareholders' equity | -35,200 | 7,200 | -16,200 | -21,700 | -20,800 |
| TOTAL | $878,800 | $835,000 | $749,400 | $690,000 | $628,100 |
| Total Liabilities And Equity | $1,400,200 | $1,349,800 | $1,246,800 | $1,229,100 | $1,112,700 |